dc.contributor.author |
Adamopoulou, Eleni |
|
dc.contributor.author |
Naumann, Ulrike |
|
dc.date.accessioned |
2017-04-07T08:27:50Z |
|
dc.date.available |
2017-04-07T08:27:50Z |
|
dc.date.issued |
2013 |
|
dc.identifier.issn |
2162-402X |
|
dc.identifier.uri |
http://hdl.handle.net/10900/75741 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Austin, Tex. : Landes Bioscience |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.4161/onci.25219 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
570 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
HDAC inhibitors and their potential applications to glioblastoma therapy |
de_DE |
dc.type |
Article |
de_DE |
utue.publikation.seiten |
;e25219 |
de_DE |
utue.personen.roh |
Adamopoulou, Eleni |
|
utue.personen.roh |
Naumann, Ulrike |
|
dcterms.isPartOf.ZSTitelID |
Oncoimmunology |
de_DE |
dcterms.isPartOf.ZS-Issue |
1 |
de_DE |
dcterms.isPartOf.ZS-Volume |
125 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |